TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SVAR Life Science AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
282,671
|
265,788
|
221,893 |
Financial expenses |
11,483
|
8,098
|
6,878 |
Earnings before taxes |
47,140
|
45,257
|
-35,197 |
EBITDA |
49,944
|
47,780
|
38,772 |
Total assets |
314,471
|
279,773
|
243,633 |
Current assets |
221,840
|
173,991
|
102,893 |
Current liabilities |
57,824
|
58,735
|
51,694 |
Equity capital |
234,390
|
194,672
|
150,730 |
- share capital |
293
![]() |
293
![]() |
293 |
Employees (average) |
122
|
120
|
123 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
74.5%
|
69.6%
|
61.9% |
Turnover per employee |
2,317
|
2,215
|
1,804 |
Profit as a percentage of turnover |
16.7%
|
17.0%
|
-15.9% |
Return on assets (ROA) |
18.6%
|
19.1%
|
-11.6% |
Current ratio |
383.6%
|
296.2%
|
199.0% |
Return on equity (ROE) |
20.1%
|
23.2%
|
-23.4% |
Change turnover |
16,883
|
43,895
|
15,522 |
Change turnover % |
6%
|
20%
|
8% |
Chg. No. of employees |
2
|
-3
|
33 |
Chg. No. of employees % |
2%
|
-2%
|
37% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.